Partek Incorporated has partnered with Kennedy Krieger Institute to develop commercial software, which will aid in analyzing genomic data from patients suffering with autism spectrum disorder and mental health disorders. Analyzing human ...
Tags: Partek, Kennedy Krieger Institute
Israel's Ministry of Health has granted an approval to Brainsway to conduct a trial to test the efficacy of Deep Transcranial Magnetic Stimulation (TMS) system in treating autism in children with low functionality levels. Brainsway TMS ...
SureGene and PGXL Laboratories have joined forces to launch the SureGene Test for Antipsychotic and Antidepressant Response (STA2R), which is a pharmacogenetic test containing genetic markers for effectiveness of antipsychotic drug ...
Tags: STA2R, SureGene Test, pharmacogenetic test
Mylan Pharmaceuticals has received final FDA approval for its abbreviated new drug application (ANDA) for Lithium Carbonate Extended-release tablets USP, 300mg. Mylan has announced immediate shipment of the generic version of Noven ...
Tags: new drug, Lithium Carbonate Extended-release tablets USP, manic episodes
Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes Catalent's Zydis fast dissolve drug delivery technology, is designed to improve ...
Tags: Catalent, Abilify Antipsychotic Drug, Otsuka Pharma, antipsychotic drug